Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symlin for Hypoglycemia After Gastric Bypass
NCT01841359Phase 4Completed
- Sponsor
- Joslin Diabetes Center
- Start
- Feb 2010
- Primary completion
- Jul 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of pramlintide in postprandial hypoglycemia, sponsored by Joslin Diabetes Center. Primary endpoint: Area Under the Curve for Plasma Glucose at 8 weeks. Started Feb 2010; status: completed.
02
Drugs
pramlintide
03
Conditions
postprandial hypoglycemia
Beyond the preview
Go deeper on NCT01841359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841359.